SHERBROOKE, Quebec, Sept. 07, 2016 (GLOBE NEWSWIRE) -- THYMOX™, the breakthrough, botanically-derived disinfectant, was selected from among over one hundred entrants to present its technology and expansion plans at the KC Animal Health Investment Forum in August. The annual event, held in Kansas City, Missouri, drew hundreds of investors from around the world, as well as most major animal health companies, that are in search of new and innovative products and technologies.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/ab63f90b-e4e2-4d4a-9f1a-d9f1786b8352
“We are delighted to be among the most innovative, early stage animal health companies to have been selected to present before the animal health investment community. The Forum came at an important time for THYMOX, as we have begun commercializing our breakthrough THYMOX footbath for dairy cows in China, and have also begun our rollout in the United States. Additionally, we received Health Canada’s approval of THYMOX HOOF™ as a drug earlier this year,” said Frank Palantoni, CEO of Laboratoire M2, the maker of THYMOX.
The effectiveness of THYMOX is based on the action of thymol, an active ingredient found in the plant thyme. THYMOX has strong anti-microbial properties and kills pathogenic micro-organisms like treponemes, the main cause of infectious lesions in dairy cows, without harming living tissue. Among the breakthrough advantages of THYMOX technology as a dairy cow footbath are its non-toxicity and biodegradability, and the fact that it promotes the healing of Digital Dermatitis lesions. This contrasts traditional foot-bath solutions that contain copper sulfate and heavy metals which are toxic, caustic, and poison the surrounding soil.
“Our company is gaining significant momentum, and we are looking forward to introducing THYMOX to the UK market with our European partner Cargill in early 2017. In addition to our Animal Health line of products, our Crop protection business has grown by over 30% this past fiscal year, and we will launch THYMOX as the active ingredient in a consumer product in the retail channel in January 2017. Our participation in the KC Animal Health Investment Forum has given us tremendous exposure as we enter our next round of funding efforts,” added Palantoni.
The company also revealed plans to enter the swine and poultry markets as the first disinfectant that can be used on trucks, and facilities, without having to clear away livestock for long periods of time in order to avoid contact, as its technology is non-toxic and not irritating.
About Laboratoire M2
Laboratoire M2, based in Sherbrooke, Canada, has a well-respected reputation for product innovation and expertise in environmentally sustainable, green disinfection and bio-security technology under the trademark THYMOX™. The company currently markets a range of leading biodegradable, disinfecting and anti-microbial products based on their proprietary technology platform, which are environmentally compliant to UL (Ecologo2794) criteria. Its line of animal health products includes THYMOX HOOF® (also sold as THYMOX FOOTBATH) which is used to protect farm animals, specifically dairy cows, from the hoof disease, digital dermatitis (DD). There are an estimated 260 million dairy cows worldwide which produce about $240 billion USD of milk annually, that are susceptible to DD. The expanding availability of THYMOX FOOTBATH throughout the global dairy industry offers farmers improved hoof health and enormous productivity savings. Additionally, the use of THYMOX will remove millions of pounds of toxic chemicals from the farm workplace and the environment. THYMOX also distributes products and ingredients under private label agreements in institutional, retail, and crop protection markets.
For more information about Laboratoire M2 and THYMOX, visit: thymox.com